P

Inventor

MALHOTRA GEENA

IN77 patents
⚠️ This page may combine multiple inventors who share the name “MALHOTRA GEENA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CIPLA LTD

37 patents
US9901585B2Feb 27, 2018

Combination of azelastine and fluticasone for nasal administration

CIPLA LTD12 citations93
USD646780SOct 11, 2011

Inhaler device

CIPLA LTD10 citations84
US8006695B2Aug 30, 2011

Inhaler

CIPLA LTD12 citations84
USD590057SApr 7, 2009

Inhaler

CIPLA LTD8 citations84
US7395821B2Jul 8, 2008

Multi-dose inhaler

CIPLA LTD13 citations84
US10301282B2May 28, 2019

Polymorphic form X of nilotinib dihydrochloride hydrate

CIPLA LTD6 citations81
US9913853B2Mar 13, 2018

Stabilized liquid fosaprepitant formulations

CIPLA LTD7 citations81
US10940274B2Mar 9, 2021

Nasal spray assembly

CIPLA LTD9 citations78
US10098890B2Oct 16, 2018

Stable carfilzomib formulations

CIPLA LTD7 citations78
USD563546SMar 4, 2008

Device for inhalation

CIPLA LTD7 citations74
US10912734B2Feb 9, 2021

Depot formulation

CIPLA LTD2 citations72
US11077124B2Aug 3, 2021

Pharmaceutical compositions

CIPLA LTD2 citations71
US10307432B2Jun 4, 2019

Stabilized liquid fosaprepitant formulations

CIPLA LTD2 citations70
US9446054B2Sep 20, 2016

Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids

CIPLA LTD2 citations63
US9259428B2Feb 16, 2016

Combination of azelastine and fluticasone for nasal administration

CIPLA LTD2 citations63
US8937057B2Jan 20, 2015

Combination of azelastine and mometasone for nasal administration

CIPLA LTD2 citations63
US8933060B2Jan 13, 2015

Combination of azelastine and ciclesonide for nasal administration

CIPLA LTD2 citations63
US11596597B2Mar 7, 2023

Depot formulation

CIPLA LTD0 citations62
US11478483B2Oct 25, 2022

Method of treating hypertension

CIPLA LTD0 citations62
US11224591B2Jan 18, 2022

Pharmaceutical compositions comprising rifaximin

CIPLA LTD0 citations62
US11207319B2Dec 28, 2021

Method for the treatment of bladder cancer

CIPLA LTD0 citations62
US11129836B2Sep 28, 2021

PAR-4 agonists for the treatment of cancer

CIPLA LTD0 citations62
US10709715B2Jul 14, 2020

Method of treating hypertension

CIPLA LTD1 citations62
US10391080B2Aug 27, 2019

Ketorolac for the treatment of cancer

CIPLA LTD1 citations62
US12472190B2Nov 18, 2025

Pharmaceutical compositions

CIPLA LTD0 citations60
US11612612B2Mar 28, 2023

Pharmaceutical compositions

CIPLA LTD0 citations60
US11234981B2Feb 1, 2022

Combination therapy for use in treating retroviral infections

CIPLA LTD1 citations60
US12090163B2Sep 17, 2024

Pharmaceutical compositions

CIPLA LTD1 citations58
US10933047B2Mar 2, 2021

Stabilized cabazitaxel formulations

CIPLA LTD0 citations57
US12324811B2Jun 10, 2025

Intranasal formulation

CIPLA LTD0 citations56
US12384784B2Aug 12, 2025

Polymorphs of Acalabrutinib, a Bruton's tyrosine kinase inhibitor

CIPLA LTD0 citations54
US7892483B2Feb 22, 2011

Sterilization process

CIPLA LTD3 citations54
US10765644B2Sep 8, 2020

Methods for the treatment of hepatitis C

CIPLA LTD0 citations52
US10149848B2Dec 11, 2018

Method for the treatment of bladder cancer

CIPLA LTD1 citations52
US10071062B2Sep 11, 2018

Methods for the treatment of hepatitis C

CIPLA LTD0 citations52
US10022377B2Jul 17, 2018

Method of treating hypertension

CIPLA LTD0 citations52
US10016377B2Jul 10, 2018

Treatment of hepatitis C using histone deacetylase inhibitors

CIPLA LTD0 citations52

LULLA AMAR

5 patents

U & I PHARMACEUTICALS LTD

3 patents

MALHOTRA GEENA

2 patents

CIPLA UK LTD

2 patents

BYRON FINE CHEMICALS INC

1 patent

Showing the top 50 of 77 patents by PatentIndex Score.